Add like
Add dislike
Add to saved papers

Treatment of polluted river water using potential bioflocculant produced by Klebsiella pneumonia UKD24.

Chemically enhanced primary treatment (CEPT) is a rapid wastewater treatment process involving treating wastewater with two chemical-aided processes, coagulation, and flocculation. In the present study, a natural extracellular polymeric substance flocculant (EPSBF) produced by Klebsiella pneumonia UKD24, a bacterium isolated from the sewage treatment plant, and a synthetic polyacrylamide anionic polymer flocculant (PAM) were evaluated to treat polluted river water. The synthetic PAM showed immediate turbidity reduction after agitation, while the EPSBF expressed a rapid decrease in optical density. After 20 min of the settling period, the EPSBF showed reduced rates of turbidity, optical density, and chemical oxygen demand at 74.14 ± 5.2%, 89.37 ± 0.76%, and 87.21 ± 0.73%, respectively, while PAM showed 67.08 ± 4%, 85.68 ± 2%, and 86.57 ± 2%, respectively. EPSBF treatment significantly improved the water quality parameters in terms of total dissolved solids, total suspended solids, conductivity, and oxidation-reduction potential than PAM treatment. However, the EPSBF has shown a more water-holding capacity and relatively weak flock formation, producing more sludge volume than PAM. Furthermore, though the sludge produced by the EPSBF treatment had a higher moisture content, it showed shorter capillary suction time (CST). In contrast, sludge formed in PAM treatment had lower moisture content, but it exhibited prolonged CST value indicating that PAM treatment sludge showed slow dewaterability.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app